American Century Companies Inc. Has $46.80 Million Stock Holdings in Cigna Group $CI

American Century Companies Inc. lessened its position in Cigna Group (NYSE:CI) by 13.7% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 162,371 shares of the health services provider’s stock after selling 25,688 shares during the period. American Century Companies Inc. owned about 0.06% of Cigna Group worth $46,804,000 as of its most recent filing with the SEC.

A number of other hedge funds have also made changes to their positions in the company. Brighton Jones LLC grew its stake in Cigna Group by 9.3% during the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock worth $1,032,000 after buying an additional 318 shares during the last quarter. Sivia Capital Partners LLC boosted its holdings in shares of Cigna Group by 10.4% in the 2nd quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider’s stock worth $384,000 after acquiring an additional 109 shares in the last quarter. Huntington National Bank boosted its stake in Cigna Group by 0.6% in the second quarter. Huntington National Bank now owns 7,664 shares of the health services provider’s stock worth $2,534,000 after purchasing an additional 43 shares in the last quarter. Prosperity Consulting Group LLC lifted its position in Cigna Group by 118.6% during the 2nd quarter. Prosperity Consulting Group LLC now owns 1,456 shares of the health services provider’s stock worth $481,000 after buying an additional 790 shares in the last quarter. Finally, NewSquare Capital LLC lifted its position in shares of Cigna Group by 38.8% during the second quarter. NewSquare Capital LLC now owns 143 shares of the health services provider’s stock worth $47,000 after purchasing an additional 40 shares in the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

More Cigna Group News

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Cigna received an independent credit-rating vote of confidence: AM Best affirmed A (Excellent) FSR and “a+” long‑term issuer credit ratings for Cigna’s core life/health subsidiaries — supports financial stability and capital strength. AM Best affirms ratings
• Positive Sentiment: Cigna formally named President & COO Brian Evanko as its next CEO (effective July 1) and said Cordani will move to executive chair; management also reaffirmed 2026 financial outlook — the internal succession and guidance reaffirmation reduce execution/guidance risk versus an outsider pick. Cigna appoints Brian Evanko
• Neutral Sentiment: Cigna executives appeared at the TD Cowen healthcare conference this week — useful for incremental detail and Q&A but not a market-moving catalyst on its own. TD Cowen presentation notice
• Neutral Sentiment: Broader health-care weakness intraday pressured peers as the NYSE Health Care Index slipped — sector moves amplify company-specific headlines but are not unique to CI. Sector update
• Negative Sentiment: Market reaction to the CEO transition has been negative in the near term — investors appear concerned about leadership change and potential strategic shifts at Evernorth/PBM despite the internal appointment. Seeking Alpha on leadership transition
• Negative Sentiment: Piper Sandler (per recent coverage) issued a cautious note on near‑term outlook for CI, which can weigh on sentiment even if other analysts remain constructive. Piper Sandler pessimistic forecast
• Negative Sentiment: Insider selling was reported (director-level sale of ~1.7k shares) — small in isolation but often cited by traders as a short-term negative signal. Insider trade filing

Insider Transactions at Cigna Group

In related news, insider Nicole S. Jones sold 2,307 shares of the stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the completion of the transaction, the insider owned 32,647 shares of the company’s stock, valued at $9,432,044.77. This represents a 6.60% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Everett Neville sold 1,719 shares of the firm’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $496,636.29. Following the sale, the insider directly owned 5,670 shares in the company, valued at approximately $1,638,119.70. This trade represents a 23.26% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 0.70% of the company’s stock.

Wall Street Analysts Forecast Growth

CI has been the subject of a number of research reports. Zacks Research raised shares of Cigna Group from a “strong sell” rating to a “hold” rating in a report on Monday, January 5th. UBS Group reissued a “buy” rating and issued a $375.00 target price on shares of Cigna Group in a research note on Monday, February 9th. Guggenheim reaffirmed a “buy” rating and set a $318.00 price target on shares of Cigna Group in a research note on Monday, February 2nd. Truist Financial raised their price objective on shares of Cigna Group from $320.00 to $350.00 and gave the company a “buy” rating in a research note on Tuesday, February 17th. Finally, Barclays reduced their target price on Cigna Group from $305.00 to $303.00 and set an “overweight” rating on the stock in a report on Friday, February 6th. One analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat, Cigna Group currently has an average rating of “Moderate Buy” and an average target price of $330.42.

Cigna Group Stock Performance

NYSE CI opened at $281.21 on Friday. The firm has a market capitalization of $74.11 billion, a P/E ratio of 12.68, a price-to-earnings-growth ratio of 0.99 and a beta of 0.27. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.74. The firm’s fifty day moving average price is $280.80 and its two-hundred day moving average price is $284.43. Cigna Group has a 1 year low of $239.51 and a 1 year high of $350.00.

Cigna Group (NYSE:CI) last released its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.88 by $0.20. The company had revenue of $72.50 billion during the quarter, compared to analysts’ expectations of $69.53 billion. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The business’s revenue was up 10.4% on a year-over-year basis. During the same period last year, the firm posted $6.64 earnings per share. Cigna Group has set its FY 2026 guidance at 30.250- EPS. As a group, research analysts anticipate that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 19th. Investors of record on Thursday, March 5th will be given a dividend of $1.56 per share. This is a positive change from Cigna Group’s previous quarterly dividend of $1.51. This represents a $6.24 annualized dividend and a yield of 2.2%. The ex-dividend date of this dividend is Thursday, March 5th. Cigna Group’s dividend payout ratio (DPR) is currently 27.23%.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.